Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Pancreatic cancer
Closed
Phase 2
This trial is looking at a new drug PM01183 to treat pancreatic cancer that has spread to other parts of the body.
Pancreatic cancer that has spread to other parts of the body is sometimes called advanced pancreatic cancer. Doctors usually treat this with chemotherapy including the drug gemcitabine. Sadly this doesn’t always work very well so doctors want to find new drugs to help people with advanced pancreatic cancer.
PM01183 is a new drug that affects how cancer cells divide and grow. Researchers want to find out if it can help people with advanced pancreatic cancer.
The aim of this trial is to find out
If PM01183 can help people with advanced pancreatic cancer that has come back or did not go away with chemotherapy
About the side effects
Recruitment start: 1 January 2012
Recruitment end: 4 December 2012
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr David Cunningham
Pharma Mar
Last reviewed: 23 November 2015
CRUK internal database number: 9640